Antimalarials should target female parasites


Disease causing organisms are notorious for their rapid evolution and their quick aquisition of resistance to the drugs used to fight them. However, in the case of the disease causing parasites Plasmodium, scientists have shown that it is the males of the species that really race ahead in the evolutionary race.

Sex is a key driver for evolution but this tends to be overlooked when looking at unicellular life forms, said Sarah Reece of Edinburgh University and her colleagues in their paper. The Plasmodium parasite, unlike humans, for example, does not have different genes coding for different sexes. Instead, sex is solely determined by which genes are expressed. Reece and colleagues placed the parasites under evolutionary pressure and observed that it was the male-biased genes that were the fast adaptors. The finding suggests that to help prevent resistance, new antimalarials should target the slower evolving female genes, or those that are expressed by both sexes.


Related Content

New antimalarial drug class resists resistance

21 March 2013 Research

news image

Drug candidate looks promising as scientists draw on past failures to address toxicity problems

Chemistry World podcast - May 2013

2 May 2013 Podcast | Monthly

news image

Robert Lovitt tells us about algae biotechnology, Patrick Holland discusses nitrogen fixing chemistry and the team cover the ...

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories